Targeted Oncology1d
FDA Grants Key Oncology Approvals and Designations in January 2025
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
Exxel Pharma's Innovative Small Molecule, EX937, Rapidly Advancing Toward First-In-Human Study for the Treatment of Refractory Chronic Cough
Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total ...
Hosted on MSN2mon
Study highlights novel non-invasive brain surgery for lasting relief from severe obsessive-compulsive disorder
Interestingly, the application of MRgFUS capsulotomy may not be just limited to refractory OCD. Dr. Chang says, "The results from our clinical trial also imply the potential role of MRgFUS in ...
Pharm Exec2d
FDA Grants Fast Track Designation to Adicet Bio’s CAR T-cell Therapy for Systemic Lupus Erythematosus
The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for ...